Single-dose/Multiple-doses Incremental Intravenous Injection of SY-005 （Recombinant Human Annexin A5）in Healthy Subjects
Clinical trial NCT04217629 · COMPLETED
Trial details
- NCT number
- NCT04217629
- Sponsor
- Suzhou Yabao Pharmaceutical R&D Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-26
- Primary completion
- 2019-10-05
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.